Plain-English translation of NCT07547163 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying how patients feel and function while receiving different treatments for a slow-growing brain tumor called an IDH-mutant grade 2 glioma. Patients in the study receive one of three standard treatment approaches: a medication called , radiation therapy, or careful monitoring with regular scans. The study focuses on capturing patients' own experiences and quality of life throughout their treatment journey.
Doctors want to understand what treatment is truly best from the patient's perspective—not just from medical tests, but from how you actually feel and function day-to-day. Your feedback will help doctors make better decisions about which approach works best for people like you.
You likely qualify if…
You likely don't qualify if…
You will continue with the treatment your doctor recommends for you—whether that's the medication, radiation, or monitoring. Every six months for two years, you'll complete questionnaires about how you're feeling, your quality of life, and how the treatment is affecting you day-to-day. You'll also have regular MRI scans and clinical check-ups as part of your normal care. The study team is simply asking you to share your voice and experience alongside your regular medical care.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
Italy